DHEA Inhibits Leukocyte Recruitment through Regulation of the Integrin Antagonist DEL-1

Autor: Tomoki Maekawa, Kyoung-Jin Chung, Sylvia Grossklaus, Triantafyllos Chavakis, Ales Neuwirth, David Sprott, Vasiliki Anastasopoulou, Markus Sperandio, George Hajishengallis, Johannes R. Wiessner, Vasileia Ismini Alexaki, Maria Troullinaki, Athanasios Ziogas, Thi Trang Le
Rok vydání: 2020
Předmět:
medicine.medical_specialty
Endothelium
medicine.medical_treatment
Immunology
Dehydroepiandrosterone
Inflammation
Immune Regulation
03 medical and health sciences
Mice
Phosphatidylinositol 3-Kinases
0302 clinical medicine
Downregulation and upregulation
Internal medicine
medicine
Cell Adhesion
Leukocytes
Immunology and Allergy
Animals
Receptor
trkA

Promoter Regions
Genetic

Protein kinase B
PI3K/AKT/mTOR pathway
030304 developmental biology
0303 health sciences
Chemistry
CCAAT-Enhancer-Binding Protein-beta
Calcium-Binding Proteins
Steroid hormone
Endocrinology
medicine.anatomical_structure
Gene Expression Regulation
CD18 Antigens
Tumor necrosis factor alpha
Female
Endothelium
Vascular

medicine.symptom
Cell Adhesion Molecules
Proto-Oncogene Proteins c-akt
030217 neurology & neurosurgery
hormones
hormone substitutes
and hormone antagonists

Signal Transduction
Zdroj: The Journal of Immunology
ISSN: 0022-1767
DOI: 10.4049/jimmunol.1900746
Popis: Leukocytes are rapidly recruited to sites of inflammation via interactions with the vascular endothelium. The steroid hormone dehydroepiandrosterone (DHEA) exerts anti-inflammatory properties; however, the underlying mechanisms are poorly understood. In this study, we show that an anti-inflammatory mechanism of DHEA involves the regulation of developmental endothelial locus 1 (DEL-1) expression. DEL-1 is a secreted homeostatic factor that inhibits β2-integrin–dependent leukocyte adhesion, and the subsequent leukocyte recruitment and its expression is downregulated upon inflammation. Similarly, DHEA inhibited leukocyte adhesion to the endothelium in venules of the inflamed mouse cremaster muscle. Importantly, in a model of lung inflammation, DHEA limited neutrophil recruitment in a DEL-1–dependent manner. Mechanistically, DHEA counteracted the inhibitory effect of inflammation on DEL-1 expression. Indeed, whereas TNF reduced DEL-1 expression and secretion in endothelial cells by diminishing C/EBPβ binding to the DEL-1 gene promoter, DHEA counteracted the inhibitory effect of TNF via activation of tropomyosin receptor kinase A (TRKA) and downstream PI3K/AKT signaling that restored C/EBPβ binding to the DEL-1 promoter. In conclusion, DHEA restrains neutrophil recruitment by reversing inflammation-induced downregulation of DEL-1 expression. Therefore, the anti-inflammatory DHEA/DEL-1 axis could be harnessed therapeutically in the context of inflammatory diseases.
Databáze: OpenAIRE